# PlasmaBound

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/plasmabound

- Industry: Materials
- Headquarters: Dublin, Ireland
- Website: www.plasmabound.com
- Total disclosed funding: $3.3M
- Latest round: Seed (Dec 22, 2022)
- Investors on record: 4

## About

Based in Ireland, PlasmaBound Ltd. specializes in advanced materials technologies, particularly its proprietary Controlled Polymer Ablation (CPA) technology, which transforms the assembly processes for the automotive and aerospace sectors.PlasmaBound Limited, founded in 2017, is headquartered in Dublin, Ireland. The company focuses on innovative materials technology solutions for automotive and aerospace applications. The founders, Alan Barry and Xavier Montibert, have been pivotal in the firm’s direction. In December 2022, PlasmaBound raised EUR 750,000 in a Seed funding round led by Business Venture Partners, bringing the total amount raised to EUR 750,000 with a current valuation of EUR 15.094 mn.PlasmaBound specializes in advanced materials technologies, focusing on its proprietary Controlled Polymer Ablation (CPA) technology, which enhances the assembly of automotive and aerospace structures. This technology allows Original Equipment Manufacturers (OEMs) to create components that are stronger, lighter, and environmentally friendly by optimizing composite materials and improving surface engineering processes. PlasmaBound's offerings address the critical challenges in the automotive and aerospace industries, serving a diverse clientele that includes leading OEMs in Europe, North America, and Asia, where demand for innovative assembly solutions is growing.PlasmaBound's revenue is generated through B2B transactions with automotive and aerospace OEMs, emphasizing partnerships and collaborations that integrate its CPA technology into manufacturing processes. The company engages in contract agreements that define deliverables and project timelines. Revenue streams include licensing agreements for CPA technology, consulting services for implementation, and ongoing support to optimize manufacturing workflows. Pricing plans are tailored based on project scope and client requirements, ensuring substantial value through its CPA technology.In December 2022, PlasmaBound Limited raised EUR 750,000 in venture funding from Business Venture Partners to advance its Controlled Polymer Ablation (CPA) technology. The company aims to utilize this funding to enhance its technology development efforts. Future growth plans include introducing new applications for CPA technology and expanding into additional markets across Europe, North America, and Asia by the end of 2024.

## Funding rounds

- Seed, Dec 22, 2022, $0.8M — Business Venture Partners
- Seed, Apr 7, 2022, $2.5M — ACT Venture Capital, Atlantic Bridge, Enterprise Ireland

## Investors

- ACT Venture Capital (https://capitalatlas.ai/funds/act-venture-capital) — Seed
- Atlantic Bridge (https://capitalatlas.ai/funds/atlantic-bridge) — Seed
- Enterprise Ireland (https://capitalatlas.ai/funds/enterprise-ireland) — Seed
- Business Venture Partners (https://capitalatlas.ai/funds/business-venture-partners) — Seed